Maladie de Still

Maladie de Still

  
Gabay C C, Fautrel B. Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease. Ann Rheum Dis. 2018 Feb
22
Lire le résumé
Pardeo M, Bracaglia C, Tulone A, Insalaco A, Marucci G, Nicolai R, et al. OP0057 EARLY TREATMENT WITH ANAKINRA IN SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS. In : Oral Presentations [Internet]. BMJ Publishing Group Ltd and European League Against Rheumatism ; 2019 [cité 26 juin 2019]. P. 100.1-100Lire le résumé
ter Haar NM, Dijkhuizen EHP, Swart JF, Royen‐Kerkhof A, el Idrissi A, Leek AP, et al. Treatment to Target Using Recombinant Interleukin‐1 Receptor Antagonist as First‐Line Monotherapy in New‐Onset Systemic Juvenile Idiopathic Arthritis : Results From a Five‐Year Follow‐Up Study. Arthritis Rheumatol [Internet]. 25 mai 2019 [cité 26 juin 2019]Lire le résumé